1-6 of 6
Etienne Paubelle, MD
Close
Sort by
Journal Articles

The Odyssee Study: Prevention of Dysbiosis Complications with Autologous Fecal Microbiota Transfer (FMT) in Acute Myeloid Leukemia (AML) Patients Undergoing Intensive Treatment: Results of a Prospective Multicenter Trial

Mohamad Mohty, MD PhD, Florent Malard, MDPhD, Anne Vekhoff, MD, Simona Lapusan, MD, Francoise Isnard, PhD, Evelyne D'Incan, Jerome Rey, MD, Colombe Saillard, MD, Xavier Thomas, MD, Sophie Ducastelle-Lepretre, MD, Etienne Paubelle, MD, Marie Virginie Larcher, MD, Clément Rocher, MD, Christian Recher, MD PhD, Suzanne Tavitian, MD, Francoise Huguet, MD, Anne-Sophie Michallet, MD PhD, Lila Gilis, MD, Pierre Peterlin, Patrice Chevallier, MD, Stephanie Nguyen-Quoc, MD, Emilie Plantamura, PhD PharmD, Lilia Boucinha, PhD, Cyrielle Gasc, PhD, Mauricette Michallet, MD PhD, Joel Doré, PhD, Ollivier Legrand, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1444.
https://doi.org/10.1182/blood-2018-99-112825
Published: 2018
Journal Articles

ABCA3 Expression Predicts Response to Gemtuzumab Ozogamicin in AML

Antony Ceraulo, Aminetou Mint-Mohamed, Delphine Maucort-Boulch, MD PhD, Etienne Paubelle, MD PhD, Xavier Thomas, MD PhD, Lea Herpe, Olivier Nibourel, PharmD, PhD, Claude Preudhomme, MD PhD, Sylvie Castaigne, MD PhD, Hervé Dombret, Eric Wattel, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3946.
https://doi.org/10.1182/blood.V128.22.3946.3946
Published: 2016
Journal Articles

A Transcriptional- and Posttranscriptional-Based Prognostic Model in Pediatric Acute Myeloid Leukemia

Antony Ceraulo, Aminetou Mint-Mohamed, Delphine Maucort-Boulch, MD PhD, Helene Lapillone, Guy Leverger, MD, Etienne Paubelle, MD PhD, Lea Herpe, Christine Ragu, PhD, Franck Mortreux, PhD, Yves Bertrand, MD PhD, Eric Wattel, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2870.
https://doi.org/10.1182/blood.V128.22.2870.2870
Published: 2016
Journal Articles

Age and Gemtuzumab Ozogamicin Influence the Prognostic Impact of TET2 Expression and Splicing in Intensively Treated Patients with Acute Myeloid Leukemia

Antony Ceraulo, Aminetou Mint-Mohamed, Delphine Maucort-Boulch, MD PhD, Helene Lapillone, Guy Leverger, MD, Etienne Paubelle, MD PhD, Xavier Thomas, MD PhD, Olivier Nibourel, PharmD, PhD, Claude Preudhomme, MD PhD, Sylvie Castaigne, MD PhD, Hervé Dombret, Lea Herpe, Christine Ragu, PhD, Yves Bertrand, MD PhD, Franck Mortreux, PhD, Eric Wattel, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3952.
https://doi.org/10.1182/blood.V128.22.3952.3952
Published: 2016
Journal Articles

Fractionated Gemtuzumab Ozogamicin Combined with Intermediate-Dose Cytarabine and Daunorubicin As Salvage Therapy in Very High Risk AML Patients: A Bridge to Reduced Intensity Conditioning Transplant?

Etienne Paubelle, MD PhD, Sophie Ducastelle, MD, Helene Labussiere, MD, Franck E. Nicolini, MD PhD, Fiorenza Barraco, MD, Adriana Plesa, Gilles A. Salles, Eric Wattel, MD PhD, Xavier Thomas, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4003.
https://doi.org/10.1182/blood.V128.22.4003.4003
Published: 2016
Journal Articles

Prognostic Impact of ABCA3 Expression in Pediatric Acute Myeloid Leukemia

Antony Ceraulo, Aminetou Mint-Mohamed, Delphine Maucort-Boulch, MD PhD, Helene Lapillone, Guy Leverger, MD, Etienne Paubelle, MD PhD, Lea Herpe, Catherine Koering, PhD, Christine Ragu, PhD, Yves Bertrand, MD PhD, Eric Wattel, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1694.
https://doi.org/10.1182/blood.V128.22.1694.1694
Published: 2016